In-vitro Study of the Inhibitory Activity of the Fractions of Onion (Allium cepa) and Shallot Bulb (Allium ascalonicum) Extracts on Angiotensin-Converting Enzyme (ACE)

Garcia, Celine Angelica and Flores, Khristy Joy and Gamalo, Mikko and Gandeza, Gezer and Garcia, Naomi Francise and Gepaya, Jenn Lori and Gerber, Maria and Go, Shera Heart and Gomez, Ore May Faith and Guinta, Sarah Myza Katrina and Herrero, Roanne Paula and Himagan, Jo Anne and Derecho, Cecile Melisse and D. Tupas, Genevieve (2022) In-vitro Study of the Inhibitory Activity of the Fractions of Onion (Allium cepa) and Shallot Bulb (Allium ascalonicum) Extracts on Angiotensin-Converting Enzyme (ACE). Journal of Pharmaceutical Research International, 34 (46B). pp. 7-16. ISSN 2456-9119

[thumbnail of 6481-Article Text-8815-2-10-20221006.pdf] Text
6481-Article Text-8815-2-10-20221006.pdf - Published Version

Download (381kB)

Abstract

The impact of hypertension as being the leading cause of death in industrialized societies pressed the importance of low-cost and accessible therapeutic agents present in food sources. This study was undertaken to evaluate the in-vitro Angiotensin-converting Enzyme (ACE) inhibitory activity of flavonoid-rich Onion and Shallot bulb extracts. Ethyl acetate, Butanol and Aqueous fractions of onion and shallot bulb extracts at varying concentrations were obtained through purification by solvent extraction. Positive control was the prototype ACE-inhibitor, Captopril. ACE-inhibitory activity was determined using the ACE-kit commercially manufactured by Dojindo, Inc. (Japan). All fractions of onion and shallot bulb extracts exhibited greater than 50% inhibitory activity towards ACE. The aqueous fractions of both bulbs showed the highest ACE-inhibitory activity exceeding the flavonoid standard, Quercetin, and were comparable with the prototype ACE-I, Captopril.

Based on the study findings, onion and shallot bulbs can be potential sources of bioactive compounds that can inhibit the activity of ACE which can be used to provide a natural, perhaps safer, cost-effective alternative in reducing blood pressure.

Item Type: Article
Subjects: Academic Digital Library > Medical Science
Depositing User: Unnamed user with email info@academicdigitallibrary.org
Date Deposited: 06 Jan 2023 10:04
Last Modified: 29 Mar 2024 04:16
URI: http://publications.article4sub.com/id/eprint/422

Actions (login required)

View Item
View Item